Medication info
Myungmoon Sarpogrelate Hydrochloride Extended-release Tablet 300 mg

Myungmoon Sarpogrelate Hydrochloride Extended-release Tablet 300 mg

Prescription medicationTablet경구
Ingredient · strength
Sarpogrelate Hydrochloride›200mg / 1 tablet
Manufacturer / importer
명문제약(주)
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903594 · Approved 2019.05.30 · Insurance code 649807450

Summary

Main use
Improvement of ischemic symptoms in chronic arterial occlusive disease (ulcer, pain, etc.)
Who takes it
Adults
Adult dose
Sarpogrelate Hydrochloride extended-release tablet 300 mg is administered orally once a day after meals. This medication should be taken whole, without chewing or crushing.

Ingredients

Manufacturer
명문제약(주)

Efficacy & effects

Improvement of ischemic symptoms in chronic arterial occlusive disease (ulcer, pain, etc.)

  • Chronic arterial occlusive disease
  • Buerger's disease
  • obstructive arteriosclerosis
  • diabetic peripheral vascular disease
  • ulcer
  • pain
  • coldness
  • ischemic symptoms
View approved original text

This medication is used to improve ischemic symptoms caused by chronic arterial occlusive disease, such as ulcers, pain, and coldness. It particularly helps alleviate circulatory disorders due to conditions like Buerger's disease, obstructive arteriosclerosis, and diabetic peripheral vascular disease, thereby assisting with symptom relief for patients. By improving blood flow in peripheral vessels, this medication promotes wound healing and reduces pain. As blood circulation improves, discomfort such as coldness also decreases. Therefore, it serves as a suitable treatment option for patients experiencing chronic coldness or pain in the extremities.

How to take

Adult dose

Sarpogrelate Hydrochloride extended-release tablet 300 mg is administered orally once a day after meals. This medication should be taken whole, without chewing or crushing.

Precautions

This medication should not be administered to patients with bleeding conditions as it may increase the risk of bleeding. It is advised that pregnant women or women who may become pregnant do not use this medication. Women who are menstruating or have a tendency to bleed should use this medication cautiously as the risk of bleeding may increase. Taking this medication with anticoagulants or antiplatelet agents may further increase the risk of bleeding, so it is essential to consult with healthcare professionals. Patients with severely impaired kidney function or elderly patients should be administered this medication carefully due to increased risk of drug elimination issues and side effects. During the course of this medication, various adverse reactions such as rash, dyspepsia, headache, and cough may occur, and if symptoms worsen, healthcare professionals should be notified immediately. Severe side effects such as bleeding, liver dysfunction, and blood disorders may occur, necessitating regular blood tests and monitoring of the patient's condition. Pregnant and breastfeeding women should ideally avoid this medication, and if unavoidable, it is safer to discontinue breastfeeding. Safety for children has not been established, so it is advisable not to use this medication in pediatric patients. This medication should be kept out of reach of children, and transferring it to other containers can cause quality degradation or accidents, so caution is advised.

Side effects and when to seek care immediately

Serious side effects

Rash, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

  • Nasopharyngitis
  • conjunctivitis
  • upper respiratory tract infection
  • dyspepsia
  • constipation
  • diarrhea
  • gastritis
  • gastrointestinal dysfunction
  • hypoglycemia
  • decreased appetite
Show 25 more
  • pain in the back
  • muscle weakness
  • headache
  • sensory disturbances
  • cough
  • blood pressure fluctuations
  • atrial fibrillation
  • anxiety
  • difficulty urinating
  • chills
  • warm sensation
  • fever
  • wounds
  • diabetic foot ulcers
  • fractures
  • myalgia
  • dizziness
  • carpal tunnel syndrome
  • spinal canal stenosis
  • exacerbation of Crohn's disease
  • hematemesis
  • liver cirrhosis
  • exacerbation of diabetes
  • angina
  • coronary artery disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.